Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5

Details for Australian Patent Application No. 2004228057 (hide)

Owner Merck & Co., Inc.

Inventors Eastman, Brian W.; Tehrani, Lida R.; Essa, Hu; Cosford, Nicholas D. P.; Huang, Dehua; Smith, Nicholas D.

Agent Spruson & Ferguson

Pub. Number AU-A-2004228057

PCT Pub. Number WO2004/089303

Priority 60/460,094 03.04.03 US

Filing date 30 March 2004

Wipo publication date 21 October 2004

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/089303 Priority application(s): WO2004/089303

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228064-Glass texturing

2004228053-Introduction apparatus